http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#head http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#assertion http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#provenance http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#publicationInfo http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#assertion http://bio2rdf.org/drugbank:DB00673 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://bio2rdf.org/drugbank:DB01285 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://purl.org/dc/terms/identifier drugbank_resource:DB00673_DB01285 http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://purl.org/dc/terms/title DDI between Aprepitant and Corticotropin - Aprepitant may increase the serum concentration of Corticosteroids (Systemic). Monitor for increased effects of systemic corticosteroids when coadmininistered with aprepitant; corticosteroid dose reduction may be necessary. The manufacturer of fosaprepitant (a prodrug of aprepitant) states that oral dexamethasone doses should be reduced by 50% when coadministered with a fosaprepitant/aprepitant regimen to achieve dexamethasone concentrations similar to those achieved with dexamethasone alone. Dexamethasone doses used in clinical chemotherapy nausea/vomiting studies with aprepitant reflect this 50% decrease. Similarly, it is recommended that in order to achieve concentrations similar to those achieved with methylprednisolone alone, the intravenous methylprednisolone dose should be reduced by 25% and the oral methylprednisolone dose should be reduced by 50% when given together with a fosaprepitant/aprepitant regimen. http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00673_DB01285 http://www.w3.org/2000/01/rdf-schema#label DDI between Aprepitant and Corticotropin - Aprepitant may increase the serum concentration of Corticosteroids (Systemic). Monitor for increased effects of systemic corticosteroids when coadmininistered with aprepitant; corticosteroid dose reduction may be necessary. The manufacturer of fosaprepitant (a prodrug of aprepitant) states that oral dexamethasone doses should be reduced by 50% when coadministered with a fosaprepitant/aprepitant regimen to achieve dexamethasone concentrations similar to those achieved with dexamethasone alone. Dexamethasone doses used in clinical chemotherapy nausea/vomiting studies with aprepitant reflect this 50% decrease. Similarly, it is recommended that in order to achieve concentrations similar to those achieved with methylprednisolone alone, the intravenous methylprednisolone dose should be reduced by 25% and the oral methylprednisolone dose should be reduced by 50% when given together with a fosaprepitant/aprepitant regimen. [drugbank_resource:DB00673_DB01285] http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#provenance http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#publicationInfo http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#signature.MC0CFQCF6PW5uSW_ http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#signature.MC0CFQCF6PW5uSW_ http://purl.org/nanopub/x/hasSignature MC0CFQCF6PW5uSW/sHqsAAeztl9Tu5sqbQIUS9JwmB82emeSu4qnceqEIfHyL+U= http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#signature.MC0CFQCF6PW5uSW_ http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://purl.org/dc/terms/created 2018-03-30T11:13:01.377+02:00 http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw#signature.MC0CFQCF6PW5uSW_ http://bio2rdf.org/drugbank_resource:DB00673_DB01285_nanopub.RAy6-IDEPhdziQeB9cArgySyA1ps67Qia4-kzvFxHPqlw http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234